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doi:10.1016/j.jtcvs.2006.07.001bjective: Aortic complications determine the life expectancy of most patients with
arfan syndrome. To find out whether there is heterogenous aortic involvement
mong patients and, if there is, to characterize aortic patterns and response to
ong-term -blocker therapy, we investigated aortic elastic properties before and
uring -blocker treatment.
ethods: In 46 patients with Marfan syndrome (age, 17.4  11.1 years) and 46
ealthy control subjects, ascending and descending aortic elastic parameters were
etermined noninvasively before and after 39  16 months of -blocker treatment
ith atenolol.
esults: Aortic diameters and distensibility distinguished Marfan patients and
ontrols with a sensitivity of 85% and a specificity of 87%. Cluster analysis revealed
patterns of aortic phenotypic expression: (1) reduced ascending aortic elasticity
46% of patients), (2) diminished ascending and descending aortic elasticity (17%),
3) minimal alterations of ascending and descending aortic elasticity (20%), and (4)
educed descending aortic elasticity (17%). During follow-up, aortic elastic prop-
rties improved in 21 (70%) of 30 patients and deteriorated in 9 (30%) irrespective
f -blocker dosage. Improvement was observed in 100% of patients (n  7; age,
.3 4.2 years) with end-diastolic aortic root diameters between 20 and 30 mm and
n 61% of patients (14/23; age, 20.5  10.0 years) with root diameters between 30
nd 52 mm.
onclusions: Aortic elastic parameters distinguish between patients with Marfan
yndrome and healthy controls and show the pattern of regional aortic involvement.
mprovement or deterioration during follow-up can influence therapeutic decisions
o prevent aortic dissection and rupture. Young age, small root diameter, and high
istensibility are favorable prognostic factors.
arfan syndrome (MFS) is an autosomal dominant connective tissue disorder
caused by mutations in the gene encoding fibrillin 1 (FBN1), with highly
variable clinical manifestations in the musculoskeletal, ocular, and cardio-
ascular systems.1,2 Recently, heterozygous mutations in the TGFBR1 and TGFBR2
enes have been reported in MFS type 2 (MFS2), Loeys-Dietz aortic aneurysm syn-
rome, and familial thoracic aortic aneurysms and dissections (see review2). The leading
ause of premature death is aortic dissection due to progressive aortic root di3
omplications are not always predictable exclusively on the basis of aortic root dimen-
ions. Notably, in a recent study of 268 MFS patients, almost 1 of every 3 aortic events
dissection or elective surgery) involved the distal aorta.4 Several studies, by usin
ifferent techniques (cardiac catheterization, echocardiography, and magnetic resonance
maging), investigated aortic hemodynamic indexes such as impedance, wave reflec-
ions, compliance, pulse wave velocity, wall stiffness index, and distensibilit5-12
evertheless, the predictive power of these parameters has not been completely clari-
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A
CDed, although some relations are known.10-12 Beta blockers
ave been shown to reduce the rate of aortic root dilation in
oth adolescent and adult patients with MFS,13 and there i
vidence of improvement in children.14 However, a heteroge-
ous response of patients to -blockers depending on aortic
iameter at the time of treatment induction was shown.15
The aim of our study was to find out whether there is
eterogeneity of aortic involvement among patients and, if
here is, to characterize different patterns of aortic involve-
ent by means of a noninvasive method and to study aortic
lastic properties before and during treatment with -block-
rs, as well as to create a model that can serve either as a
arker for the presence of MFS or as a noninvasive tool to
ssess aortic wall abnormalities during follow-up.
ethods
atients and Control Subjects
ur study population consisted of 46 individuals (15 males and 31
emales) with MFS according to the Ghent criteria.16 Age ranged
etween 7 months and 47 years (mean, 17.4  11.1 years).
hysical features were documented and graded according to the
onsensus of 2 physicians (D.B. and E.S.), according to a stan-
ardized protocol. Mutation analysis of the FBN1 gene was per-
ormed in 26 MFS patients as described elsewhere.12,17 Before the
nitial investigation, no patient received a -blocker, angiotensin-
onverting enzyme inhibitor, or calcium antagonist or had a history
f aortic dissection or aortic surgery. Of 32 patients (9 men and 23
omen) available for follow-up investigations, 30 were treated
rally with a -blocker (atenolol 0.79  0.46 mg · kg1 · d1)
ecause of aortic dilatation for the entire follow-up period. The
ndividual dose was adjusted to the largest dose that was clinically
olerated (maximum, 2 mg/kg body weight). No follow-up inves-
igation was possible in 14 of 46 patients because 2 had an aortic
oot replacement operation shortly after the initial examination, 9
ere examined for the first time less than 1 year before data
cquisition for this study was completed (our protocol prescribed
early intervals), 2 patients had moved and were followed up by
ther institutions thereafter, and 1 patient refused to participate in
he study. In all 14, information about clinical course and therapy
as obtained from the attending physician or patient.
According to our protocol, data were obtained before and
uring -blocker treatment at 18 7 months (early follow-up) and
9  16 months (late follow-up) after the initial investigation. In
atients who had an aortic root replacement operation (n  6; 4
ith follow-up), the last preoperative investigation was taken as
ate follow-up in order not to include investigations of tube grafts
Abbreviations and Acronyms
AscAo  ascending aorta
DescAo descending aorta
FBN1  the gene encoding fibrillin 1
MFS Marfan syndrome
MSAI maximum systolic area increasend of aortic segments, which are influenced by prosthetic mate- r
12 The Journal of Thoracic and Cardiovascular Surgery ● Octoial. The mean age at late follow-up was 19.9  11.0 years.
orty-six age- and sex-matched healthy subjects (some of them
ere healthy relatives of patients with MFS) constituted the con-
rol group and were examined once. Clinical characteristics of
atients and controls are shown in Table 1. The protocol
pproved by the institutional review board on human research.
ritten informed consent was obtained from all individuals.
chocardiographic Evaluation and Calculation of
ortic Parameters
ll subjects underwent a complete transthoracic echocardio-
raphic examination by using commercially available equipment
System Five [General Electric Vingmed Ultrasound, Horten, Nor-
ay] or Acuson Sequoia C512 [Siemens Medical Solutions,
ountain View, Calif]). Two-dimensional guided M-mode mea-
urements of the left ventricle were performed according to the
ecommendations of the American Society of Echocardiography18
natomy and function of the mitral and aortic valve were assessed
y 2-dimensional echocardiography, color flow mapping, and
ulsed-wave and continuous-wave Doppler recordings. We esti-
ated the presence of mitral valve prolapse by using established
uidelines.19 M-mode tracings of the ascending (AscAo) and -
cending (DescAo) aortic wall motions were obtained in the left
ecubitus position according to published criteria20 by using 2
imensional guidance at 4 different levels, as described.12,21,22:
evel 1, annulus (parasternal short-axis view); level 2, sinuses of
alsalva; level 3, proximal AscAo 10 to 20 mm (in infants, 5 to 10
m) distal to the sinotubular junction (both parasternal long-axis
iews); and level 4, descending abdominal aorta just proximal to
he branching of the celiac trunk (abdominal paramedian long-axis
iew). Accurate imaging of AscAo and DescAo was achieved in
ll patients and controls. All images were digitally stored as raw
ata with EchoPAC System version 6.4.1 (General Electric). Aor-
ic dilatation was determined with standard nomograms.20
We calculated aortic diameters continuously at levels 3 and 4
y using software developed by 2 of us (C.B. and D.B.12,21
veraged time-diameter curves of at least 4 heart cycles and
veraged threefold supine systolic and diastolic blood pressure
easurements, which were taken according to the recommenda-
ions of the American Heart Association23 at the right arm osc-
ometrically (Dinamap; GE Healthcare, Slough, UK) immediately
efore M-mode registration, served for the automatic calculation
f aortic elastic parameters. The method was validated and tested
or its reproducibility, as described.12 A detailed description o
arameters, namely, systolic diameter increase, distensibility, stiff-
ess index,24 maximum systolic area increase (MSAI), vec
ortographic magnitude, and phase, is given in Appendix 1.
ata Analysis
Hierarchical cluster analysis. MFS patients were clustered
nto meaningful subgroups by taking solely aortic parameters into
ccount. Each generated cluster thus represents a characteristic
attern of aortic abnormality based on the similarity of its aggre-
ate expressions (Hierarchical Clustering Explorer 2.0, University
f Maryland, College Park, Md).
Logistic regression model. Aortic parameters, selected by a
orward search strategy, were used as the input to a logistic
egression model. Here, a probability measure in the form of
ber 2006
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A
CDP(z 1) 1 ⁄ 1 exp(z) ,
here z a0 a1x1 a2x2. . . anxn, is the logit of the model,
etermines the class membership. P(MFS  1) means that MFS is
resent if P  .5 and that MFS is absent if P  .5. To evaluate
ollow-up data, the meaning of the dependent variable P(MFS 
) was changed to P(aortic abnormality  1). Fivefold cross-
alidation was applied to validate the experimental results (WEKA
.4.4, University of Waikato, Hamilton, New Zealand).
Statistical analysis. Data are expressed as mean  SD. Un-
aired continuous variables were compared by means of unpaired
tudent t tests and Mann-Whitney U tests, respectively. For com-
arisons of more than 2 variables, the H-test (Kruskal-Wallis) was
erformed. Paired variables were compared by using the paired t
est or Wilcoxon test (SPSS 11.0; SPSS Inc, Chicago, Ill).
esults
linical Characteristics
linical characteristics of the Marfan patients and control
ersons are summarized in Table 1. Thirty-four pati
74%) had echocardiographic signs of mitral valve prolapse.
ystolic left ventricular function, indicated by fractional
ABLE 1. Clinical characteristics and aortic parameters o
ariable
o. patients
ge (y)
eight (kg)
eight (cm)
SA (m2)
eart rate (/min)
ystolic blood pressure (mm Hg)
iastolic blood pressure (mm Hg)
ulse pressure (mm Hg)
ortic root
Diastolic diameter (mm)
Diastolic diameter/BSA (mm/m2)
scending aorta
Diastolic diameter (mm)
Diameter/BSA (mm/m2)
Systolic diameter increase (%)
Distensibility (kPa1 · 103)
Stiffness index
Maximum systolic area increase (%/100 ms)
escending aorta
Diastolic diameter (mm)
Diameter/BSA (mm/m2)
Systolic diameter increase (%)
Distensibility (kPa1 · 103)
Stiffness index
Maximum systolic area increase (%/100 ms)
ector aortography
Magnitude (%)
Phase (°)
SA, Body-surface area; NS, not significant. Data are shown as mean hortening, was normal in all patients (34.0%  4.3%) and t
The Journal of Thoracicontrols. In 43 patients (93%) dilatation of the aortic root
as identified, and in 19 (41%), dilatation of the AscAo was
dentified. Thirteen patients (28%) presented with aortic
egurgitation (9 grade I, 2 grade II, and 2 grade III),
nd 29 (63%) presented with mitral regurgitation (14 grade
, 13 grade II, and 2 grade III), as defined by color-
oded Doppler echocardiography. We did not observe wors-
ning of aortic or mitral regurgitation during follow-up.
hirty patients (65%) had a family history of MFS. Muta-
ion analysis of FBN1 in 26 patients revealed a substitution/
issense mutation in 8 patients, a substitution/nonsense
utation in 6, a deletion/frameshift  premature termina-
ion codon mutation in 6, an indel mutation in 1, a splice site
utation in 3, and no mutation in 2 patients. Two siblings
howed a mutation of TGFBR2. All mutations but 1 were
ew, unpublished ones. Details are available upon request.
ortic Dimensions and Calculation of Elastic
arameters
chocardiographic aortic findings of the Marfan group and
ients with Marfan syndrome (MFS) and control persons
FS Controls P value
46 46
 11.1 17.6 11.1 NS
 20.6 50.2 21.7 NS
 28.0 155.6 28.3 NS
 0.46 1.47 0.45 NS
 18.7 74.0 21.9 NS
 12.2 116.1 11.9 NS
 10.9 64.3 8.7 NS
 10.6 51.8 10.1 NS
 11.7 26.0 6.7 .001
 6.7 18.7 4.7 .001
 9.7 21.3 6.1 .001
 4.7 15.3 4.0 .001
 8.6 18.8 7.3 .001
 23.2 61.1 25.8 .001
 7.3 3.6 1.3 .001
 16.4 53.7 25.4 .001
 5.1 12.6 3.3 NS
 2.8 9.1 2.5 NS
 6.8 19.1 6.4 .002
 28.2 63.3 27.5 .004
 4.9 3.5 1.7 .001
 23.1 52.0 19.4 NS
 7.0 26.4 8.0 .001
 31.6 46.4 12.8 .009f pat
M
17.4
51.6
166.2
1.54
70.2
115.0
62.8
52.2
36.4
24.8
26.7
18.0
9.2
32.8
9.1
28.1
13.7
9.2
14.9
48.6
5.5
46.5
19.0
61.0he control group are shown in Table 1. In patients, AscAo
and Cardiovascular Surgery ● Volume 132, Number 4 813
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A
CDnd DescAo elastic parameters, such as systolic diameter
ncrease and cross-sectional distensibility, were signifi-
antly decreased, whereas the stiffness index was increased
ompared with healthy controls. MSAI was reduced in the
scAo of patients, but not in the DescAo. Linear regression
nalysis showed a close correlation between distensibility
nd MSAI in the AscAo and DescAo of patients (P  .001;
Figure 1. Hierarchical cluster analysis of diameters an
in 46 MFS patients revealed—at a similarity cutoff of 0.5
(upper box). Age, percentage of aortic dilatation, v
calculated from clustering results, were different betw
different among all 4 clusters (P < .05). Aortic schem
lines) AscAo and DescAo wall alterations. Family mem
clusters. 0.815). The vector aortographic magnitude of patients A
14 The Journal of Thoracic and Cardiovascular Surgery ● Octoas diminished, and phase was significantly increased, thus
ndicating a more severe impairment of the AscAo than
escAo systolic diameter increase.
luster Analysis
ecause of the phenotypic variability of aortic wall alter-
tions, we performed a hierarchical cluster analysis of
stic parameters of the AscAo, DescAo, and aortic root
clusters representing 4 different aortic patterns of MFS
r aortographic magnitude, and phase, which were
clusters (lower box). *Aortic parameters significantly
r each cluster show severe (thick lines) or mild (thin
sharing the same mutation were spread over differentd ela
— 4
ecto
een
es fo
bersscAo and DescAo parameters in all 46 patients to form
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A
CDeaningful subgroups. The following parameters were in-
luded (Figure 1): normalized aortic root, AscAo 
escAo diameters, AscAo and DescAo diameter increase,
istensibility, MSAI, and wall stiffness index. Four clusters
merged: Cluster 1 (n  21) showed decreased AscAo
lasticity. Cluster 2 (n  8) consisted of patients with
everely diminished AscAo and DescAo elastic properties,
hereas Cluster 3 (n  9) showed very mild AscAo and
escAo alterations in a very young patient group (mean
ge, 9.7 years vs 17.6  10.9 years in controls) not signif-
cantly different from those of healthy controls. Neverthe-
ess, dilatation of the aortic root was present in all 9 cases.
luster 4 (n  8) consisted of patients with severely re-
uced DescAo elasticity accompanied by mild AscAo al-
erations not significantly different from those of controls.
ixteen of 21 patients in cluster 1, 3 of 8 patients in cluster
, 6 of 9 in cluster 3, and 7 of 8 in cluster 4 had follow-up
nvestigations of aortic parameters. Notably, 3 (37.5%) of 8
atients of cluster 2 had an aortic root replacement opera-
ion after the latest investigation, whereas in clusters 1, 3,
nd 4, root replacement was necessary in only 9.5% (n 2),
%, and 12.5% (n  1) of patients.
ogistic Regression Models
ortic parameters were tested to distinguish between MFS
atients and healthy controls. A cross-validated multiple
ogistic regression model built on 46 patients and 46 con-
rols, including 4 parameters (normalized aortic root and
scAo diameters; AscAo and DescAo distensibility), dis-
riminated with the highest sensitivity (85.1%), specificity
87.2%), and overall accuracy (correctly classified individ-
als of both groups/all individuals of both groups; 86.2%)
etween the 2 groups. The mean probability P(presence of
FS) was 81.6%  24% for the MFS group and 18.4% 
ABLE 2. Clinical characteristics and aortic diameters of
ariable First inve
atient characteristics
n 3
Months of follow-up
Beta-blocker dose (mg · kg1 · d1)
Heart rate (/min) 70
Systolic blood pressure (mm Hg) 114
Diastolic blood pressure (mm Hg) 64
iameters
Aortic root (mm) 34.8
Aortic root/BSA (mm/m2) 24.5
AscAo (mm) 25.9
AscAo/BSA (mm/m2) 18.0
DescAo (mm) 12.7
DescAo/BSA (mm/m2) 8.8
scAo, Ascending aorta; BSA, body-surface area; DescAo, descending a2.6% for the control group. Model coefficients, signifi- .
The Journal of Thoracicance of parameters, and odds ratios are displayed in
ppendix 1.
ollow-up Investigation
bsolute diameters increased in the aortic root (P  .001),
he AscAo (P .048), and the DescAo (P .001), whereas
iameters normalized to body-surface area decreased in the
ortic root (P  .003) and the AscAo (P  .004) and
emained unchanged in the DescAo (Table 2). AscAo 
escAo elastic parameters (diameter increase, distensibil-
ty, stiffness index, magnitude, and phase) tended to im-
rove, and MSAI tended to decrease, but differences were
ot statistically significant.
To determine the severity of aortic wall disease during
ollow-up, data were sorted according to aortic root diam-
ter and AscAo distensibility (Figure 2). We therefore
erpreted the probability P of our multiple logistic regres-
ion model, which included solely aortic parameters, as a
easure of aortic abnormality. The overall P(aortic abnor-
ality) of 30 patients decreased significantly from 78% 
7% to 68%  34% at early follow-up (P  .01) and
hereafter remained unchanged (69% 32%) at late follow-
p. In 21 (70%) of 30 MFS patients, P(aortic abnormality)
ecreased from 79%  28% to 63%  34% after 18  4
onths (P  .003) and remained at 58%  33% (21%) at
he last investigation after 41 16 months of follow-up and
o indicated improvement of elasticity. In the remaining 9
atients (30%), P(aortic abnormality) changed insignifi-
antly from 75%  24% to 77%  35% after 18  11
onths but increased further to 93%  6% after 31  16
onths of follow-up (18%; P  .05), as a sign of deterio-
ation of aortic wall mechanics. Neither the mean follow-up
ime (P  .164) nor the mean -blocker dosage (0.78 
.50 mg · kg1 · d1 vs 0.82  0.36 mg · kg1 · d1; P 
fan patients during follow-up
tion Last investigation P value
30
39 16
0.79  0.46
57  11 .001
111  10 NS
60  9 .036
36.2  8.4 .001
21.9  4.1 .003
26.8  7.5 .048
16.3  3.9 .004
14.3  3.5 .001
8.6  1.4 NS
S, not significant. Data are mean  SD.Mar
stiga
0
0
0
 22
 12
 10
 8.9
 6.9
 8.4
 4.6
 3.6
 2.2756) of the 2 groups was statistically different. P(aortic
and Cardiovascular Surgery ● Volume 132, Number 4 815
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A
CDbnormality) decreased in all patients with aortic root di-
meters between 20 and 30 mm (Figure 2, A; left subgroup)
n 62% with diameters between 30 and 40 mm (middle), and
n 60% with diameters between 40 and 52 mm (right).
If data were sorted according to AscAo distensibility
Figure 2, B), the probability P(aortic abnormality) de
reased in 100% of patients with an AscAo distensibility
etween 45 and 83 kPa1 · 103, in 75% of patients with a
istensibility between 30 and 45 kPa1 · 103, and in 40%
ith a distensibility between 0 and 30 kPa1 · 103. The
-blocker dose did not differ significantly among these 3
ubgroups (H-test).
The pattern of aortic abnormality did not change during
ollow-up, because the vector aortographic maximum mag-
Figure 2. Probability P(aortic abnormality) at the initial
the diameter of the aortic root (A) and AscAo distensib
all patients with root diameters less than 30 mm and/itude and phase of clusters remained unchanged. Solely in s
16 The Journal of Thoracic and Cardiovascular Surgery ● Octoluster 1 with predominant AscAo elasticity impairment (n
16), P(aortic abnormality) decreased and, therefore, elas-
icity improved at the late follow-up investigation, explicitly
rom 85.2%  22.0% to 69.5%  27.8% (15.6%; P 
027). The mean P(aortic abnormality) values of clusters 2
initially 97.2%), cluster 3 (53.4%), and cluster 4 (78.6%)
emained unchanged.
Not surprisingly, the youngest patients were found in the
roups with the smallest diameters and the greatest disten-
ibility, whereas in both patients who had not received
-blockers (11 and 31 years old), P(aortic abnormality)
ncreased (from 55.6% to 79.8% and from 54.2% to 89.3%,
espectively). All patients who had undergone aortic root
eplacement operation after our examinations belonged to a
nd final (2) investigation in 30 MFS patients sorted for
(B). Note the improvement of P(aortic abnormality) of
cAo distensibility greater than 45 kPa1 · 103.(1) a
ility
or Asubgroup with aortic root diameters greater than 44 mm and
ber 2006
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A
CDscAo distensibility between 0 and 27 kPa1 · 103 at the
nitial investigation (Figure 2, right subgroup). Their in
(aortic abnormality) ranged between 68% and 100% (me-
ian, 99%) and improved in 2 of 4 cases at late follow-up
uring -blocker treatment.
iscussion
ur study demonstrated that aortic wall changes of patients
ith MFS followed 4 different patterns: involvement of
scAo (46% of our patients), severe AscAo and DescAo
hanges (17%), mild AscAo and DescAo changes not sig-
ificantly different from normal (20%), and dominant
escAo involvement (17%). One-half of the patients (3 of
) who had an elective aortic root replacement operation
fter our examinations were in cluster 2, with severe AscAo
nd DescAo wall alterations; none were in cluster 3, with
ild AscAo and DescAo changes. This means that 3 of 8
atients in cluster 2 had to be operated on on the basis of
onventional criteria for surgical intervention. Therefore,
luster 2 might be regarded as a risk group for aortic
omplications; in cluster 3, the risk should be lowest. His-
ologic examinations in patients with MFS revealed that
lastin fragmentation in the aortic media is scattered in an
rregular pattern along the aorta.25 Investigations of patient
ith fusiform AscAo aneurysms disclosed media degener-
tion of the AscAo wall.26 Here, the predominance o
scAo changes probably reflects the ratio of elastic fiber to
ollagen, which varies from 3.1:1 in the proximal AscAo to
.8:1 in the midthoracic region and 0.8:1 in the abdominal
egion.11,27 In a study of 192 patients with MFS who-
erwent aortic aneurysm repair, 16% had their initial oper-
tion for aortic dissection in the DescAo.28 We speculate
hat our subgroup with DescAo changes perhaps is at risk
or DescAo complications.
It is well known that degenerative aortic changes in
arfan patients parallel alterations due to normal aging,
hich can be measured in terms of arterial stiffness.29 Mild
scAo and DescAo changes not significantly different from
ormal controls were seen in our youngest patient subgroup
cluster 3). Older patients were subdivided into 3 subgroups
ith either (1) AscAo, (2) severe AscAo and DescAo, or (3)
erely DescAo changes. In family members sharing the
ame mutation, different aortic patterns were observed. Dur-
ng a follow-up time of 39 months, our patients did not
hange their pattern of aortic involvement, which underlines
he results of a study which showed that local initial diam-
ters were the major predictors of progressive aortic root
nd abdominal aortic dilatation.11 Longer follow-up studie
ay show the change from insignificant to severe aortic
lterations.
The 4 key features determining aortic abnormality in our
ultiple logistic regression model were the following: aor-
ic root and AscAo diameters normalized to body-surface c
The Journal of Thoracicrea and AscAo and DescAo distensibility. The model dis-
inguished with high sensitivity (85%) and specificity (87%)
etween MFS patients and healthy control subjects. Be-
ause of its suitability, this model was successfully intro-
uced into our daily clinical practice.
Probability measures resulting from logistic regression
nalysis clearly quantify clinical situations determined by
ultiple factors and, thereby, can indicate improvement or
eterioration during follow-up. M-mode registration at ex-
ctly the same aortic sites, which is essential for comparison
f results, can be performed accurately by our method. Our
odel revealed that P(aortic abnormality) decreased and
herefore showed improvement in 100% of patients with
ortic root diameters less than 30 mm during follow-up and
reatment with -blockers, whereas improvement occurred
nly in approximately 60% of patients with root diameters
reater than 30 mm. In a study of 13 adult patients with
FS,15 8 responded to a single dose of metoprolol w
ecrease of stiffness index (responders). The group of the 5
onresponders was characterized by an increasing stiffness
ndex and more dilated AscAo. In analogy, 100% of our
atients with an AscAo distensibility more than 45 kPa1 ·
03 improved, 75% with a distensibility between 30 and
5 kPa1 · 103 improved, and only 40% with a distensi-
ility less than 30 kPa1 · 103 improved. Improvement
ould already be observed after 18 months of -blocker
reatment, whereas deterioration occurred gradually and
eached significance at late follow-up. It is interesting to
ote that only the cluster 1 patient group with AscAo wall
hanges showed a positive response to -blocker treatment,
ndicated by an improvement of P(aortic abnormality). The
mallness of clusters 2 to 4 has to be taken into account, and
esults must be viewed cautiously.
Our study does have a limitation. The descending tho-
acic aorta cannot be examined by our investigation method.
his should regularly be done by additional cine-magnetic
esonance imaging.
A recent prospective study in a mouse model of aortic
neurysm provides a newer understanding of many aspects
f MFS that were shown to be caused by dysregulation and
nhanced signaling of the transforming growth factor 
amily of cytokines.30 Fibrillin-1 shares a high degree 
omology with the latent transforming growth factor
–binding proteins. Aortic aneurysm in this study could be
revented by transforming growth factor  antagonists such
s transforming growth factor –neutralizing antibody or
he angiotensin II type 1 receptor blocker losartan, a drug
lready in clinical use for hypertension. Our logistic regres-
ion model could perhaps be a useful tool to prove these
romising results in a randomized controlled trial of losar-
an and -blockers in humans.
In summary, our multiple logistic regression model in-
luding solely AscAo and DescAo parameters is a sensitive
and Cardiovascular Surgery ● Volume 132, Number 4 817
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A
CDool to determine the probability of MFS. If P(aortic abnor-
ality) is high, the similarity to 1 of the 4 clusters probably
hows the aortic region to be at risk for complications.
ollow-up investigations during pharmacologic therapy can
onitor its success. We observed improvement of aortic
all changes in patients with predominant AscAo wall
bnormality, in all (young) patients with aortic root diam-
ters less than 30 mm, and in those with AscAo distensi-
ility more than 45 kPa1 · 103. These findings underscore
he usefulness of early pharmacologic therapy. Finally,
n increase of P(aortic abnormality) can be used as
dditional argument to indicate prophylactic surgical aor-
ic intervention.
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ppendix 1: Aortic parameters
1. Systolic diameter increase:
(Ds Dd) ⁄ Dd (%),
where Ds is systolic (maximum) and Dd is end-diastolic
(minimum) aortic diameter. The cross-sectional aortic dis-
tensibility and stiffness index were estimated as previously
described.7,12,21,24
2. Distensibility:
As Ad
Ad · (Ps Pd) · 1333
· 107 (kPa1 · 103),
3. Stiffness index:
ln(Ps ⁄ Pd)
(Ds Dd) ⁄ Dd
(dimensionless),
ber 2006
L
M
N
N
A
D
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A
Baumgartner et al Surgery for Acquired Cardiovascular Diseasewhere As is systolic and Ad is end-diastolic area and Ps is
systolic and Pd is diastolic blood pressure (mm Hg). Area A
was determined as (D/2)2 · .
4. Maximum systolic area increase (MSAI) was defined as the
maximum systolic slope of the area-time curve A(t) nor-
malized to Ad:
MSAI
d
dt
((A(t) ⁄ Ad 1) · 100)|max (% ⁄ 100 ms)
The vector aortography visualizes the vector loop of theThe Journal of Thoracicchanges during the heart cycle. The rotating vector can be
characterized by its magnitude (vector length) and phase
(vector angle).
5. Magnitude (t):
(D(t) ⁄ Dd1) · 100AscAo2  (D(t) ⁄ Dd1) · 100DescAo2 (%),
6. Phase (t):
arctan (D(t) ⁄ Dd 1)DescAo(D(t) ⁄ Dd 1)AscAo  (°)A
CDrelative AscAo (x-axis) and DescAo (y-axis) diameter where D(t) is the aortic diameter/time curve.
ogistic regression model
odel parameter Regression coefficient SE P value Odds ratio
ormalized root diameter (mm/m2) 0.842 0.201 .001 2.321
ormalized AscAo diameter (mm/m2) 0.727 0.215 .001 0.483
scAo distensibility (kPa1 · 103) 0.098 0.027 .001 0.907
escAo distensibility (kPa1 · 103) 0.033 0.015 .028 0.968
ntercept 0.352 1.795 .844 1.422
scAo, Ascending aorta; DescAo, descending aorta.and Cardiovascular Surgery ● Volume 132, Number 4 819
